Stockreport

Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF entered into an exclusive licensing and collaboration agreement with Eisai Co. Ltd. to expand the global reach of its lung cancer pill. Taletrectinib is currently appr [Read more]